Results 121 to 130 of about 3,191 (210)

Revisiting the Role of Lorazepam as an Adjunct in the Management of Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis. [PDF]

Biomedicines
Peng TR, Lin HH, Wu TW, Hsu CY.
europepmc   +1 more source

Chemotherapy-Induced Nausea and Vomiting (CINV) [PDF]

Egyptian Journal of Hematology and Bone Marrow Transplantation, 2017
openaire   +1 more source

Risk prediction models for chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis. [PDF]

Front Oncol
Xie X, Li H, Li Y, Fu H, Wang Y, Cheng J.   +5 more
europepmc   +1 more source

Efficacy and safety of transcutaneous electrical acupoint stimulation and acupressure in alleviating chemotherapy-related adverse reactions in female patients with breast cancer: a randomized clinical trial. [PDF]

Front Oncol
Yuan J, Chu J, Hu X, Zhao X, Li H, Zhang B, Baihong L, Han J, Tao Z, Kayishaer T, Tian C, Zhu B, Yang Y.   +12 more
europepmc   +1 more source

Megestrol acetate versus dexamethasone to prevent nausea and vomiting in patients with gastric or gastro-oesophageal junction cancer treated with oxaliplatin-based chemotherapy: study protocol of a multicentre, randomised, non-inferiority trial. [PDF]

BMJ Open
Luo H, Hu Q, Zeng L, Huang Q, Luo Y, Li T, Chen P, Yi C, Gou H.   +8 more
europepmc   +1 more source

Moving beyond promethazine: Advancing precision in antiemetic therapy. [PDF]

SAGE Open Med
Ryan MF, Lagasse C.
europepmc   +1 more source

Multiple-day dexamethasone for controlling delayed chemotherapy-induced nausea and vomiting with low-emetic-risk chemotherapy. [PDF]

BMC Cancer
Yamashita A, Hayashi T, Shimokawa M, Harimitsu Y, Nishijima Y, Uchiyama M, Ushio S, Shiraishi C, Miyoshi T, Koutake Y, Kawada K, Matsuo K, Egawa T.   +12 more
europepmc   +1 more source

Efficacy and Safety of Oral NEPA Versus Fosaprepitant Plus Palonosetron for Preventing Chemotherapy-Induced Nausea and Vomiting in Patients with Nasopharyngeal Carcinoma: A Propensity-Score-Matched Retrospective Study. [PDF]

Cancers (Basel)
Cai Y, Zeng Y, Li Q, Yi G, Yang D, Deng T, Li X, Luo H.   +7 more
europepmc   +1 more source

A randomized, double-blind, placebo-controlled trial of olanzapine versus placebo plus ondansetron and dexamethasone for antiemetic prophylaxis in patients receiving oxaliplatin-, irinotecan-, or carboplatin-based chemotherapy. [PDF]

Support Care Cancer
Harikul W, Nimmannit A, Laocharoenkeat A, Phisalprapa P, Kositamongkol C, Thongkijpreecha P, Ithimakin S.   +6 more
europepmc   +1 more source

Symptoms Experienced by Breast Cancer Patients Before, During and After Chemotherapy: A Systematic Review. [PDF]

Int J Womens Health
Cao Y, Lee K, Yusuf A, Chen ST, Dong X, Li L, Lim PY.   +6 more
europepmc   +1 more source